Literature DB >> 21457678

Temporal relationships between overweight and obesity and DSM-IV substance use, mood, and anxiety disorders: results from a prospective study, the National Epidemiologic Survey on Alcohol and Related Conditions.

Roger P Pickering1, Risë B Goldstein, Deborah S Hasin, Carlos Blanco, Sharon M Smith, Boji Huang, Attila J Pulay, W June Ruan, Tulshi D Saha, Frederick S Stinson, Deborah A Dawson, S Patricia Chou, Bridget F Grant.   

Abstract

OBJECTIVE: To present nationally representative findings on the prospective relationships between overweight and obesity and DSM-IV substance use, mood, and anxiety disorders.
METHOD: A nationally representative sample of 34,653 US adults was interviewed in Wave 1 (2001-2002) and Wave 2 (2004-2005) of the National Epidemiologic Survey on Alcohol and Related Conditions. The target population was the civilian population residing in households and group quarters, with gathered data adjusted to be representative of the civilian population of the United States on the basis of the 2000 Decennial Census. The main outcome measures were the incidence of DSM-IV substance use, mood, and anxiety disorders and changes in body mass index status during the 3-year follow-up period.
RESULTS: Regression analyses that controlled for a wide array of covariates showed that overweight and obese women were at increased risk (P < .05) for incident major depressive disorder during the follow-up period (adjusted OR [AOR] = 1.3 [95% CI, 1.02-1.56] and AOR = 1.2 [95% CI, 1.02-1.51], respectively). Overweight men and obese men were at decreased risk (P < .05) of incident drug abuse and alcohol dependence (AOR = 0.7 [95% CI, 0.44-0.96] and AOR = 0.7 [95% CI, 0.52-0.97]), respectively. Obese women had a decreased risk (P < .05) of incident alcohol abuse and drug dependence (AOR = 0.6 [95% CI, 0.45-0.88] and AOR = 0.4 [95% CI, 0.21-0.91], respectively). Men with drug dependence and women with specific phobia had a decreased risk (P < .05) of becoming overweight or obese during the follow-up period (AOR = 0.4 [95% CI, 0.19-0.99] and AOR = 0.8 [95% CI, 0.66-0.95], respectively).
CONCLUSIONS: Increased risk of major depressive disorder among overweight and obese women could be attributed to stigma and greater body dissatisfaction among women in Western cultures. Overweight and obesity may serve as protective factors against developing incident substance use disorders, possibly due to shared neural functions in the brain underlying addictions to numerous substances. Results are discussed in terms of their clinical implications, including the need to update treatment guidelines for the management of overweight, obesity, and major depressive disorder. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21457678      PMCID: PMC3227748          DOI: 10.4088/JCP.10m06077gry

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  66 in total

1.  Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study.

Authors:  D S Pine; P Cohen; J Brook; J D Coplan
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

2.  Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN.

Authors:  L B Cottler; B F Grant; J Blaine; V Mavreas; C Pull; D Hasin; W M Compton; M Rubio-Stipec; D Mager
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

3.  Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study.

Authors:  C B Pull; J B Saunders; V Mavreas; L B Cottler; B F Grant; D S Hasin; J Blaine; D Mager; B T Ustün
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

4.  Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule--Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison.

Authors:  S Chatterji; J B Saunders; R Vrasti; B F Grant; D Hasin; D Mager
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

5.  The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample.

Authors:  D Hasin; K M Carpenter; S McCloud; M Smith; B F Grant
Journal:  Drug Alcohol Depend       Date:  1997-03-14       Impact factor: 4.492

6.  Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene.

Authors:  D E Comings; R Gade; J P MacMurray; D Muhleman; W R Peters
Journal:  Mol Psychiatry       Date:  1996-09       Impact factor: 15.992

7.  The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample.

Authors:  B F Grant; T C Harford; D A Dawson; P S Chou; R P Pickering
Journal:  Drug Alcohol Depend       Date:  1995-07       Impact factor: 4.492

8.  The relation between body mass index, mental health, and functional disability: a European population perspective.

Authors:  Ronny Bruffaerts; Koen Demyttenaere; Gemma Vilagut; Montserat Martinez; Anke Bonnewyn; Ron De Graaf; Josep Maria Haro; Sebastian Bernert; Matthias C Angermeyer; Traolach Brugha; Christine Roick; Jordi Alonso
Journal:  Can J Psychiatry       Date:  2008-10       Impact factor: 4.356

9.  Bias in reported body weight as a function of education, occupation, health and weight concern.

Authors:  R W Jeffery
Journal:  Addict Behav       Date:  1996 Mar-Apr       Impact factor: 3.913

10.  Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample.

Authors:  Amber A Mather; Brian J Cox; Murray W Enns; Jitender Sareen
Journal:  J Psychosom Res       Date:  2008-11-22       Impact factor: 3.006

View more
  23 in total

1.  Does co-morbid depression alter the inverse relationship between obesity and substance use disorders?

Authors:  Ashley N Gearhardt; Emily L R Harrison; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2012-01-28       Impact factor: 4.492

Review 2.  Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC.

Authors:  Deborah Hasin; Bari Kilcoyne
Journal:  Curr Opin Psychiatry       Date:  2012-05       Impact factor: 4.741

Review 3.  Sex differences in drug addiction and response to exercise intervention: From human to animal studies.

Authors:  Yuehui Zhou; Min Zhao; Chenglin Zhou; Rena Li
Journal:  Front Neuroendocrinol       Date:  2015-07-13       Impact factor: 8.606

4.  Depressive Disorder Subtypes as Predictors of Incident Obesity in US Adults: Moderation by Race/Ethnicity.

Authors:  Brittanny M Polanka; Elizabeth A Vrany; Jay Patel; Jesse C Stewart
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

5.  Obesity stigma as a determinant of poor birth outcomes in women with high BMI: a conceptual framework.

Authors:  Sharon Bernecki DeJoy; Krystle Bittner
Journal:  Matern Child Health J       Date:  2015-04

Review 6.  Sex Differences in Obesity and Mental Health.

Authors:  Jena Shaw Tronieri; Courtney McCuen Wurst; Rebecca L Pearl; Kelly C Allison
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

7.  Obesity and the three-year longitudinal course of bipolar disorder.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Ayal Schaffer; Regina Sala; Carlos Blanco
Journal:  Bipolar Disord       Date:  2013-01-03       Impact factor: 6.744

Review 8.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

9.  Prospective Changes in Healthy Lifestyle Among Midlife Women: When Psychological Symptoms Get in the Way.

Authors:  Claudia Trudel-Fitzgerald; Shelley S Tworoger; Elizabeth M Poole; David R Williams; Laura D Kubzansky
Journal:  Am J Prev Med       Date:  2016-06-09       Impact factor: 5.043

10.  RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats.

Authors:  Nori Geary; Thomas Bächler; Lynda Whiting; Thomas A Lutz; Lori Asarian
Journal:  Appetite       Date:  2015-12-17       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.